(2-Oxo-2,3-dihydrobenzo[d]oxazol-6-yl)boronic acid, 95.0%, 5g

1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), min. 98%, for synthesis, 100 ml, glass packaging

tert-Butyl 3-(cyanomethyl)piperazine-1-carboxylate, 97%, 250mg

Methyl 4-chloro-2,6-difluorobenzoate, 95.0%, 25g

2-(Diethoxymethyl)oxirane, 90%,Containing phenylacetonitrile stabilizer, 100mg

6-Bromophthalazin-1(2H)-one, 95.0%, 100g

1,8-NAPHTHYRIDINE-2,4-DIOL, 95.0%, 5g

1-(3-chloro-4-methylphenyl)-3-methyl-1H-pyrazol-5-amine, 95.0%, 250mg

2-Methoxy-3-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 10g

5-methyl-4-phenyl-4H-1,2,4-triazole-3-thiol, 1g

Double neck round bottom flasks side neck parallel, 100 ml, 14/23, 1 Piece

2-Bromoquinoline-6-carbonitrile, 97%, 250mg

Campesterol, ��98.0%, 5mg